Abstract
A series of N-guanidino substituted 2,4-diamino-5-carbonylguanidine molecules related to amiloride were synthesised and evaluated for their ability to inhibit the sodium–calcium exchanger in rat insulinoma cells (RINm5F) and human platelets. Specific chemical pathways were used to prepare the benzene derivatives designed as bioisosteric analogues of the pyrazine derivatives of amiloride. Several so-called ‘simplified analogues’, where some substituents of amiloride were omitted or replaced, were also prepared and included in the biological evaluation. The inhibitory potency of the sodium–calcium exchanger was screened on both cell types by measuring their effect on 45Ca 2+ uptake. Among the most active compounds, N-(2-amino-5-chloro-4-nitrobenzoyl)- N′-(1-naphtylmethyl)guanidine (IC 50=3.4 μM) was found more active than amiloride (IC 50=690 μM) and 3,4-dichlorobenzamil (IC 50=15.2 μM), the reference inhibitor.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
